LABORATORY RESEARCH Maintenance of Hematopoietic Stem Cells through Regulation of Wnt and mTOR Pathways Scientists report that suppression of the mTOR pathway, an established nutrient sensor, combined with activation of canonical Wnt-β-catenin signaling, allows for the ex vivo maintenance of human and mouse long-term hematopoietic stem cells under cytokine-free conditions. [Nat Med] Abstract Wt1-Specific T-Cell Responses in High-Risk Multiple Myeloma Patients Undergoing Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantation and Donor Lymphocyte Infusions Researchers examined the significance of WT1-specific T-cells responses in patients with relapsed multiple myeloma and high-risk cytogenetics who were undergoing allogeneic T-cell-depleted hematopoietic stem cell transplantation followed by donor lymphocyte infusions. [Blood] Abstract Myelopoiesis Is Regulated by Osteocytes through Gsα-Dependent Signaling Osteocytes are thought to initiate adaptive bone remodeling responses via osteoblasts and osteoclasts. The authors report that these cells regulate hematopoiesis, constraining myelopoiesis through a Gsα-mediated mechanism that affects G-CSF production. [Blood] Abstract Implantable Microenvironments to Attract Hematopoietic Stem/Cancer Cells Scientists described the manufacture and image-guided monitoring of an engineered microenvironment with user-defined properties that recruits hematopoietic progenitors into the implant. [Proc Natl Acad Sci USA] Abstract Transcription Factor Oct1 Is a Somatic and Cancer Stem Cell Determinant The authors showed that Oct1 promotes tumor engraftment frequency and promotes hematopoietic stem cell engraftment potential in competitive and serial transplants. [PLoS Genet] Full Article STAT5 Is Crucial to Maintain Leukemic Stem Cells in Acute Myeloid Leukemias Induced by MOZ-TIF2 MOZ-TIF2 is a leukemogenic fusion oncoprotein that confers self-renewal capability to hematopoietic progenitor cells and induces acute myeloid leukemia with long latency in bone marrow transplantation assays. Investigators report that FLT3-ITD transforms hematopoietic cells in cooperation with MOZ-TIF2 in vitro and in vivo. [Cancer Res] Abstract Expression of Integrin A2 Receptor in Human Cord Blood CD34+CD38-CD90+ Stem Cells Engrafting Long-Term in Nod/Scid-Il2rγcNull Mice The authors report that primitive cord blood CD34+CD38-CD90+ stem cells, with the ability to reconstitute NOD/SCID-IL2Rγcnull mice long term, at 24 weeks after transplantation, can be prospectively isolated at an increased purity by using integrin α2 receptor as an additional stem cell marker. [Stem Cells] Abstract Inhibition of T Cell Protein Tyrosine Phosphatase (TC-PTP) Enhances IL-18-Dependent Hematopoietic Stem Cell Expansion Researchers report that inhibition of T cell protein tyrosine phosphatase, an enzyme involved in the regulation of cytokine signaling, through gene knockout results in a nine-fold increase in the number of hematopoietic progenitors in murine bone marrow. [Stem Cells] Abstract Association between B-Cell Receptor Responsiveness and Disease Progression in B-Cell Chronic Lymphocytic Leukemia: Results from Single Cell Network Profiling Studies B-cell receptor signaling proteins were functionally characterized by single cell network profiling in samples from patients with B-cell chronic lymphocytic leukemia in an exploratory study after stimulation with anti-IgM. [Haematologica] Abstract | Full Article CLINICAL RESEARCH Physicians Compliance during Maintenance Therapy in Children with Down Syndrome and Acute Lymphoblastic Leukemia Researchers reviewed Methotrexate/Mercaptopurine maintenance therapy data for children with Down syndrome (DS) treated according to the NOPHO ALL92 or the NOPHO ALL2000 protocols. The five year event-free survival for the 66 DS patients was inferior to the 2602 non-DS patients. [Leukemia] Abstract Improved Outcome for Children with Non-High Risk Acute Lymphoblastic Leukemia after Using an ALL IC-BFM 2002-Based Protocol in Shanghai, China The authors report the outcome of 92 non-high risk children with acute lymphoblastic leukemia (ALL) following a Berlin-Frankfürt-Münster (BFM) Intercontinental ALL-based protocol. [Br J Haematol] Abstract |